EVC Group Alternative

EVC Group for life sciences. AxonIR for life sciences + AI.

AxonIR is the AI-native investor relations firm for NYSE and NASDAQ micro/small-cap companies. Save $42,000 – $108,000/year vs EVC Group while gaining 12 AI capabilities they cannot match at any price.

EVC Group vs AxonIR — Side by Side

Legacy

EVC Group

Monthly$5,000–$10,000/month
FocusLife sciences & tech small-caps
AI Capabilities✗ None
ContractAnnual commitment
  • EVC Group retainer $5K–$10K/mo
  • Sector expertise but no AI/NLP technology
  • Limited algo signal monitoring
  • No short-seller early warning
  • No activist threat prediction
Recommended
AI-Native

AxonIR

Monthly$750–$4,000
FocusNYSE/NASDAQ <$500M + AI
AI Capabilities✓ 12 native
ContractMonth-to-month
  • Sector expertise + AI platform. AxonIR handles life sciences, tech, SaaS, industrials with equally sophisticated NLP scoring — plus a dedicated analyst at Scale/Enterprise tier.
  • 50-80% savings. $1,500–$4,000 vs $7,500/mo average.
  • Biotech short-seller defense. Biotechs face the most short-seller attacks. AxonIR&apos;s early warning system is critical for sector-specific defense.

You Save $42,000 – $108,000/year

Replacing EVC Group with AxonIR cuts your IR spend 50-90% while adding AI capabilities that make you visible to the 70% of trading that is algorithmic.

See Your Free Algo Score

Why Companies Switch from EVC Group to AxonIR

01

Sector expertise + AI platform

AxonIR handles life sciences, tech, SaaS, industrials with equally sophisticated NLP scoring — plus a dedicated analyst at Scale/Enterprise tier.

02

50-80% savings

$1,500–$4,000 vs $7,500/mo average.

03

Biotech short-seller defense

Biotechs face the most short-seller attacks. AxonIR&apos;s early warning system is critical for sector-specific defense.

Ready to leave EVC Group?

Start with a free algo score. No credit card required.